Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats

Journal of Ethnopharmacology

Volumn 108, Issue 1, 2006, Pages 109-115

  Tang, Li Qin ^a   Wei, Wei ^a   Chen, Li Ming ^a   Liu, Sheng ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidant effect; Berberine; Diabetes; Hypoglycemic effect; Hypolipidemic effect; Nitric oxide

Indexed keywords

ALLOXAN; BERBERINE; CHOLESTEROL; GLUCOSE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID DIET; MALE; MICROSCOPY; NONHUMAN; PANCREAS INJURY; PROTEIN BLOOD LEVEL; RAT; SCORING SYSTEM; SPECTROPHOTOMETRY; TRIACYLGLYCEROL BLOOD LEVEL;

ALLOXAN; ANIMALS; BERBERINE; BLOOD GLUCOSE; COPTIS; DIABETES MELLITUS, EXPERIMENTAL; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOGLYCEMIC AGENTS; MALE; PANCREAS; PHYTOTHERAPY; RATS; RATS, WISTAR;

RATTUS NORVEGICUS;

EID: 33749327046     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2006.04.019     Document Type: Article

References (37)

1. Aksoy N., Vural H., Sabuncu T., and Aksoy S. Effects of melatonin on oxidative-antioxidative status of tissues in streptozotocin-induced diabetic rats. Cell Biochemistry and Function 21 (2003) 121-125
2. Arvind K., Pradeepa R., Deepa R., and Mohan V. Diabetes & coronary artery disease. Indian Journal of Medical Research 116 (2002) 163-176
3. Asayama K., Hayashibe H., Dobashi K., Niitsu T., Miyao A., and Kato K. Antioxidant enzyme status and lipid peroxidation in various tissues of diabetic and starved rats. Diabetes Research 12 (1989) 85-91
4. Augustin A.J., Breipohl W., Boker T., Lutz J., and Spitznas M. Increased lipid peroxide levels and myloperoxidase activity in the vitreous of patients suffering from proliferative diabetic retinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology 231 (1993) 647-650
5. Benzie I.F., and Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Analytical Biochemistry 239 (1996) 70-76
6. Bhatnagar D. Lipid-lowering drugs in the management of hyperlipidaemia. Pharmacology and Therapeutics 79 (1998) 205-230
7. Bonnardel-Phu E., and Vicaut E. Reactive oxygen species and acute modulation of albumin microvascular leakage in the microcirculation of diabetic rats in vivo. Journal of Vascular Research 37 (2000) 32-38
8. Brownlee M., Vlassara H., and Cerami A. Non-enzymatic glycosylation and the pathogenesis of diabetic complications. Annals of Internal Medicine 101 (1984) 527-537
9. Ceriello A., Bortolotti N., Falleti E., Taboga C., Tonutti L., Crescentini A., Motz E., Lizzio S., Russo A., and Bartoli E. Total radical-trapping antioxidant parameter in NIDDM patients. Diabetes Care 20 (1997) 194-197
10. Chaput E., Maubrou-Sanchez D., Bellamy F.D., and Edgar A.D. Fenofibrate protects lipoproteins from lipid peroxidation:synergistic interaction with alpha-tocopherol. Lipids 34 (1999) 497-502
11. Damci T., Tatliagac S., Osar Z., and Ilkova H. Fenofibrate treatment is associated with better glycemic control and lower serum leptin and insulin levels in type 2 diabetic patients with hypertriglyceridemia. European Journal of Internal Medicine 14 (2003) 357-360
12. Draper H.H., and Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods in Enzymology 186 (1990) 421-431
13. Ellman G.L. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics 82 (1959) 70-77
14. Freeman B.A., and Crapo J.D. Biology of disease: free radicals and tissue injury. Laboratory Investigation 47 (1982) 412-426
15. Hunt J.V., Smith C.C., and Wolff S.P. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39 (1990) 1420-1424
16. Kakkar P., Das B., and Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Indian Journal of Biochemistry and Biophysics 21 (1984) 130-132
17. Kashiwagi A., Asahina T., Nishio Y., Ikebuchi M., Tanaka Y., Kikkawa R., and Shigeta Y. Glycation, oxidative stress, and scavenger activity: glucose metabolism and radical scavenger dysfunction in endothelial cells. Diabetes 3 (1996) S84-S86
18. Kiechle F.L., and Malinski T. Nitric oxide, Biochemistry, pathophysiology,and detection. American Journal of Clinical Pathology 100 (1993) 567-575
19. Krause B.R., and Princen H.M. Lack of predictability of classical animal models for hypolipidemic activity:a good time for mice?. Atherosclerosis 140 (1998) 15-24
20. Leng S.H., Lu F.E., and Xu L.J. Therapeutic of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacologica Sinica 25 (2004) 496-502
21. Li Q.G., Sun R., and Gao F.Z. Effect of Shen Di Jiang Tang Granules on diabetic rats. China Journal of Chinese Materia Medica 26 (2001) 488-490
22. Li W.L., Zheng H.C., Bukuru J., and De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. Journal of Ethnopharmacology 92 (2004) 1-21
23. Liu S., Tang L.Q., and Chen L.M. Study on extraction technology of berberine from Rhizoma coptidis by the method of orthogonal-test optimization. China Pharmacy 15 (2004) 18-20
24. May L.D., Lefkowitch J.H., Kram M.T., and Rubin D.E. Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy. Annals of Internal Medicine 136 (2003) 449-452
25. McCord J.M., and Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). The Journal of Biological Chemistry 244 (1969) 6049-6055
26. Njoroge F.G., and Monnier V.M. The chemistry of the Maillard reaction under physiological conditions: a review. Progress in Clinical and Biological Research 304 (1989) 85-107
27. Pan G.Y., Wang G.J., Sun J.G., Huang Z.J., Zhao X.C., Gu Y., and Liu X.D. Inhibitory action of berberine on glucose absorption. Yao Xue Xue Bao 38 (2003) 911-914
28. Reiter R.J. Oxidative processes and antioxidative defense mechanisms in the aging brain. The FASEB Journal 9 (1995) 526-533
29. Robertson R.P. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. The Journal of Biological Chemistry 279 (2004) 42351-42354
30. Rubio A.R., and Morales-Segura M.A. Nitric oxide, an iceberg in cardiovascular physiology: far beyond vessel tone control. Archives of Medical Research 35 (2004) 1-11
31. Sharma S.B., Nasir A., Prabhu K.M., Murthy P.S., and Dev G. Hypoglycaemic and hypolipidemic effect of ethanolic extract of seeds of Eugenia jambolana in alloxan-induced diabetic rabbits. Journal of Ethnopharmacology 85 (2003) 201-206
32. Soon Y.Y., and Tan B.K. Evaluation of the hypoglycemic and antioxidant activities of Morinda officinalis in streptozotocin-induced diabetic rats. Singapore Medical Journal 43 (2002) 077-085
33. Taskinen M.R. Diabetic dyslipidemia. Atherosclerosis 3 (2002) 47-51
34. Trinder P. Determination of blood glucose using an oxidase peroxidase system with a non-carcinogenic chromogen. Journal of Clinical Pathology 22 (1969) 158-161
35. Vallejo S., Angulo J., Peiro C., Nevado J., Sanchez-Ferrer A., Petidier R., Sanchez-Ferrer C.F., and Rodriguez-Manas L. Highly glycated oxyhaemoglobin impairs nitric oxide relaxations in human mesenteric microvessels. Diabetologia 43 (2000) 83-90
36. Xie W., Xing D., Sun H., Wang W., Ding Y., and Du L. The effects of Ananas comosus L. leaves on diabetic-dyslipidemic rats induced by alloxan and a high-fat/high-cholesterol diet. The American Journal of Chinese Medicine 33 (2005) 95-105
37. Zhang J.T. Modern Experimental Methods in Pharmacology (1998), Beijing medical university, Beijing p. 982